Navigation Links
In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression

ectively, were:
  • Overall Pain 20.3 percent, 17.9 percent;
  • Headache 25.6 percent, 15.6 percent;
  • Back Pain 18.2 percent, 20.2 percent;
  • Shoulder Pain 17.9 percent, 16.2 percent;
  • Interference with Daily Activities 29.5 percent, 23.2 percent;
  • Time in Pain While Awake 28.8 percent, 26.3 percent.

Efficacy, safety, and tolerability outcomes following direct switch from SSRI to duloxetine were similar to those observed for start-taper switch. Few patients experienced a serious adverse event (5 patients during the 10 weeks of treatment and 1 during the taper period), and there was a low rate of discontinuations due to adverse events (6.6 percent DS vs. 3.8 percent STS).

This was an open-label study, so biases inherent in open-label studies could have been a factor in the observed outcomes. Due to the large number of possible SSRI/dose possibilities for patients entering the study, it was necessary for study investigators to use their clinical judgment to devise an appropriate 2-week down-titration regimen for patients in the STS group. Although general guidance was provided to investigators within the study protocol, the taper was nevertheless not rigidly standardized.

About Duloxetine
While duloxetine’s mechanism of action in humans is not fully known, it is believed to affect both serotonin and norepinephrine/noradrenaline mediated nerve signalling in the brain and the spinal cord. Based on pre-clinical studies, duloxetine is a balanced and potent reuptake inhibitor of serotonin and norepinephrine/noradrenaline. Scientists believe its effect on pain perception is due to increasing the activity of serotonin and norepinephrine in the central nervous system.

Duloxetine is approved for the treatment of depression and diabetic peripheral neuropathic pain in many countries and is approved in some countries for the treatment of stress urinary
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. In New Study, Duloxetine Reduced Non-specific Pain and Emotional Symptoms Associated with Depression
2. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
3. Roxro Pharma’s Novel Intranasal Pain Reliever Effective, Well Tolerated in Phase 3 Study
4. MabThera Significantly Increases Survival of Lymphoma Patients Regardless of Chemotherapy Regimen
5. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
6. Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid Arthritis
7. The Lancet Publishes PREVAIL Study Results Showing Lovenox Superiority Over Unfractionated Heparin for Reducing the Risk of Venous ThromboEmbolism in Patients With Acute Ischemic Stroke
8. The International Myeloma Foundation Says New Clinical Trial Results Could Improve Survival While Reducing Side Effects For Many Patients
9. New Study Confirms Role for Pertussis Immunization of Entire Family in Reducing Infant Pertussis
10. Dharma Therapeutics Shows IDDS Is Effective in Reducing Pain Associated With Insertion of an Intravenous Catheter in Their Phase 2 Clinical Trial
11. Pooled Studies Showed Desvenlafaxine Succinate Significantly Improved Painful Symptoms and Anxious Symptoms Associated with Major Depressive Disorder in Adults, Compared With Placebo
Post Your Comments:
(Date:8/28/2014)... MONICA, Calif. , Aug. 28, 2014  In anticipation ... new infographic is being made available for the first time. ... San Diego offers a snapshot of ... industry. Highlighting everything from the latest employment statistics ... has made San Diego such a ...
(Date:8/28/2014)... LAKE CITY , Aug. 28, 2014 /PRNewswire-iReach/ -- ... 2000 by service academy graduates, has published a ... concentrated, three-day Leadership Excellence Course . In September ... Leadership Excellence Course to Albuquerque , ... Tucson . Photo - http://photos.prnewswire.com/prnh/20140828/140814 ...
(Date:8/28/2014)... LONDON , Aug. 28, 2014  A candidate ... The Gambia and Mali ... safety trials of potential vaccines aimed at preventing the disease that ... West Africa . Human trials of ... Health (NIH) and GlaxoSmithKline, are to be accelerated with funding from ...
Breaking Medicine Technology:New Infographic Published - Overview of Medtech & Life Sciences Industry in San Diego 2Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 2Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 3Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 4Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 5Ebola vaccine trials fast-tracked by international consortium 2Ebola vaccine trials fast-tracked by international consortium 3Ebola vaccine trials fast-tracked by international consortium 4Ebola vaccine trials fast-tracked by international consortium 5Ebola vaccine trials fast-tracked by international consortium 6Ebola vaccine trials fast-tracked by international consortium 7
... ALBUQUERQUE, N.M., Jan. 26, 2011 ... Board: NMXC ), a developer of medical IT ... the healthcare community, announced today the implementation of a software ... its XR-EXpress telemedicine services to other systems. CEO ...
... SAN DIEGO, Jan. 26, 2011 The following statement ... LLP pursuant to an order of the United States ... TES DISTRICT COURTSOUTHERN DISTRICT OF NEW YORKHOWARD LEVINE, Individually ... Plaintiff, , vs. , ATRICURE, INC., et al., , ...
Cached Medicine Technology:Correction: New Mexico Software Unveils Additional Software Significantly Expanding Availability of Its Telemedicine Services 2Correction: New Mexico Software Unveils Additional Software Significantly Expanding Availability of Its Telemedicine Services 3Robbins Geller Rudman & Dowd LLP Announces Notice of Hearing to Determine Approval of Proposed Settlement of Class Action 2
(Date:8/29/2014)... August 29, 2014 As a chiropractic ... Fla., understands that there’s a direct connection between the ... hips and back. "Since conventional shoe inserts and orthotics ... solution of my own," he said. , Customizable to ... better support for the foot in order to help ...
(Date:8/29/2014)... (HealthDay News) -- The main strain of a ... and North Africa originated in sub-Saharan Africa, a ... methicillin-resistant Staphylococcus aureus (CA-MRSA) infections, which ... been hospitalized. These infections typically affect the skin ... through touching contaminated objects such as clothing or ...
(Date:8/29/2014)... For the fifth year in a row, ... observing September 26th as Mesothelioma Awareness Day, by attending ... , Members of the community who wish to ... will be providing t-shirts and signs to participating community ... have received attention from Al Roker and ...
(Date:8/29/2014)... PreDiabetes Centers , the country’s leading prediabetes treatment ... shoppers a 20% discount off orders of $100 or more ... living shop, beginning September 1. , Keeping your body ... the chilly fall season. , Autumn’s cooler, cozier weather often ... ditch the healthy salads and opt for creamy soups, hearty ...
(Date:8/29/2014)... Innovations Television, produced by DMG Productions, announced today ... focusing on health and elderly care, slated to air first ... Americans over 65 will nearly double by 2030, expanding from ... for a total of 72 million people. Though many older ... least one chronic condition and use healthcare services more often ...
Breaking Medicine News(10 mins):Health News: European MRSA Originated in Sub-Saharan Africa, Study Finds 2Health News:Organization to Raise Awareness of Mesothelioma on the Today Show 2Health News:PreDiabetes Centers Online Store Launches Fall Savings Event 2Health News:Innovations with Ed Begley, Jr., Seeking Content for Upcoming Series on Health and Elder Care 2
... Jonas in Los Angeles and,Become Part of "Team Jonas" ... To kick off Diabetes Awareness,Month, Bayer Diabetes Care announced ... meet teen pop sensation Nick Jonas of the Jonas,Brothers ... These Grand Prize winners will meet Nick Jonas in ...
... CLEMSON Clemson University researchers developing imaging agents to ... received $180,000 from the Susan G. Komen Breast Cancer ... cancer deaths in American women. , The new method ... resonance imaging) that may help researchers look at different ...
... University of Bristol brings stem cell therapies for heart ... bodies, ability to respond to an internal ,mayday, signal ... medicine. , Dr Nicolle Krnkel and colleagues at the ... DIY rescue and repair mechanisms when blood supply is ...
... kick off American,Diabetes Month this November, the American ... Detroit, along with Eli,Lilly and Company,s national educational ... Diabetes Update, an educational program for people affected ... Saturday, November 1, at the Greater,Grace Temple, 23500 ...
... from the Blue Cross Blue,Shield of Michigan Foundation ... elementary schools to help youngsters learn healthy lifestyle,habits ... University will use a BCBSM Foundation grant to ... and Redner --,part of Lincoln Consolidated Schools -- ...
... 30 Even though many hospitals have not,taken ... surgery,processes, those that do see significant improvements in ... case study recently,published by Kermit Randa of Surgical ... Group, Inc., outlines the benefits realized through the,implementation ...
Cached Medicine News:Health News:Bayer Diabetes Care Names 'Walk In Nick's Shoes' (W.I.N.S.) Sweepstakes Grand Prize Winners 2Health News:Bayer Diabetes Care Names 'Walk In Nick's Shoes' (W.I.N.S.) Sweepstakes Grand Prize Winners 3Health News:Susan G. Komen Breast Cancer Foundation awards grant for imaging-agent research 2Health News:Stem cell therapies for heart disease -- 1 step closer 2Health News:American Diabetes Association and Eli Lilly and Company Unite to Educate and Empower African-Americans with Diabetes 2Health News:American Diabetes Association and Eli Lilly and Company Unite to Educate and Empower African-Americans with Diabetes 3Health News:Blue Cross Blue Shield of Michigan Foundation Grant to Eastern Michigan University Will Help Ypsilanti Elementary Schoolchildren Lead Healthier Lives 2Health News:Blue Cross Blue Shield of Michigan Foundation Grant to Eastern Michigan University Will Help Ypsilanti Elementary Schoolchildren Lead Healthier Lives 3Health News:Healthcare Providers Improve Financial, Clinical and Operational Efficiencies Through IT 2
The Perfecta IMC Stems, manufactured from forged cobalt- chrome, are specifically designed for cemented femoral stem arthroplasty....
The APR Hip System offers a complete line of stems to precisely match patients' anatomic needs and address surgeon preferences....
Simple straight stem design for the low-demand patient....
Dual offset femoral stems, hip stems that provide unique and competitive features....
Medicine Products: